Journal of Affective Disorders
Volume 86, Issue 1 , Pages 61-67 , May 2005

1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients

  • Paolo Brambilla

      Affiliations

    • Division of Mood and Anxiety Disorders, Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
    • Department of Pathology and Experimental and Clinical Medicine, Section of Psychiatry, University of Udine School of Medicine, Udine, Italy
    • Advanced Biotechnology Center, University of Genova, Genova, Italy
  • ,
  • Jeffrey A. Stanley

      Affiliations

    • Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  • ,
  • Mark A. Nicoletti

      Affiliations

    • Division of Mood and Anxiety Disorders, Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
  • ,
  • Roberto B. Sassi

      Affiliations

    • Advanced Biotechnology Center, University of Genova, Genova, Italy
    • Department of Psychiatry, Institute of Psychiatry, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
    • Department of Psychiatry, Harvard Medical School, Boston, USA
  • ,
  • Alan G. Mallinger

      Affiliations

    • Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  • ,
  • Ellen Frank

      Affiliations

    • Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  • ,
  • David Kupfer

      Affiliations

    • Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  • ,
  • Matcheri S. Keshavan

      Affiliations

    • Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  • ,
  • Jair C. Soares

      Affiliations

    • Division of Mood and Anxiety Disorders, Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
    • Department of Radiology, University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA
    • South Texas Veterans Health Care System, San Antonio, TX, USA
    • Corresponding Author InformationCorresponding author. Division of Mood and Anxiety Disorders, Department of Psychiatry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA. Tel.: +1 210 5675492; fax: +1 210 5673759.

Received 6 October 2004 ,Accepted 10 December 2004.

References 

  1. Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol. Psychiatry. 2003;53:906–913
  2. Chang KD, Adleman N, Dienes K, Barnea-Goraly N, Reiss A, Ketter T. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol. Psychiatry. 2003;53(11):1059–1065
  3. Chen RW, Chuang DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J. Biol. Chem. 1999;274:6039–6042
  4. Deicken RF, Eliaz Y, Feiwell R, Schuff N. Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Res. 2001;106:35–45
  5. Hamakawa H, Kato T, Murashita J, Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur. Arch. Psychiatry Clin. Neurosci. 1998;248:53–58
  6. Hamakawa H, Kato T, Shioiri T, Inubushi T, Kato N. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychol. Med. 1999;29:639–644
  7. Hellweg R, Lang UE, Nagel M, Baumgartner A. Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats. Mol. Psychiatry. 2002;7:604–608
  8. Jackson GD, Duncan JS. MRI anatomy: a new angle on the brain. New York: Churchill Livingstone; 1996;
  9. Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y, Takahashi S, et al. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J. Psychiatry Neurosci. 1996;21:248–254
  10. Manji HK, Moore GJ, Rajkowska G, Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol. Psychiatry. 2000;5:578–593
  11. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?. Biol. Psychiatry. 2000;48:1–8
  12. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK, Menji HK. Lithium-induced increase in human brain grey matter. Lancet. 2000;356:1241–1242
  13. Ohara K, Isoda H, Suzuki Y, Takehara Y, Ochiai M, Takeda H, et al. Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Res. 1998;84:55–60
  14. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord. 2002;4:105–116
  15. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol. Psychiatry. 2001;49:741–752
  16. Sassi RB, Nicoletti M, Brambilla P, Mallinger AG, Frank E, Kupfer DJ, et al. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci. Lett. 2002;329:243–245
  17. Sharma R, Venkatasubramanian PN, Barany M, Davis JM. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr. Res. 1992;8:43–49
  18. Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int. Clin. Psychopharmacol. 2003;18:73–79
  19. Soares JC. Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder. Int. J. Neuropsychopharmacol. 2003;6:171–180
  20. Soares JC, Krishnan KR, Keshavan MS. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Depression. 1996;4:14–30
  21. Spitzer RL, Williams JBW, Gibbon M, First MG. Structured clinical interview for DSM-III-R (SCID). Washington, DC: American Psychiatric Press; 1994;
  22. Stanley JA. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Can. J. Psychiatry. 2002;47:315–326
  23. Stanley JA, Pettegrew JW, Keshavan MS. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part I. Biol. Psychiatry. 2000;48:357–368
  24. Stanley JA, Panchalingam K, Keshavan MS, Soares JC, Pettegrew JW. A post-processing method to accurately quantify N-acetylaspartate in short echo time in vivo 1H spectra. In: Proceedings of the International Society of Magnetic Resonance in Medicine, Berkeley, CA. 2002;p. 2514
  25. Stoll AL, Renshaw PF, Sachs GS, Guimaraes AR, Miller C, Cohen BM, et al. The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study. Biol. Psychiatry. 2002;32:944–949
  26. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 1993;13:981–989
  27. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol. Psychiatry. 2000;47:475–481
  28. Yuh WTC, Tali ET, Afifi AK, Sahinoglu K, Gai F, Bergman RA. MRI of head and neck anatomy. New York: Churchill Livingstone; 1994;

PII: S0165-0327(04)00444-6

doi: 10.1016/j.jad.2004.12.008

Journal of Affective Disorders
Volume 86, Issue 1 , Pages 61-67 , May 2005